Consolidated Financial Results

for the Nine Months Ended September 30, 2021

[Japanese GAAP]

November 8, 2021

Company name: GMO Pepabo, Inc.

Stock exchange listing: Tokyo Stock Exchange

Code number: 3633

URL: https://pepabo.com/

Representative: Kentaro Sato, CEO and President

Contact: Yoshito Igashima, CFO and Board Director

Phone: +81-3-5456-3021

Scheduled date of filing quarterly securities report: November 9, 2021

Scheduled date of commencing dividend payments: ―

Availability of supplementary briefing material on quarterly financial results: Available

Schedule of quarterly financial results briefing session: Scheduled (for institutional investors and analysts)

(Amounts of less than one million yen are rounded down.)

1. Consolidated Financial Results for the Nine Months Ended September 30, 2021 (from January 1, 2021 to September 30, 2021)

(1) Consolidated Operating Results

(% indicates changes from the previous corresponding period.)

Net sales

Operating profit

Ordinary profit

Profit attributable to

owners of parent

Nine months ended

Million yen

%

Million yen

%

Million yen

%

Million yen

%

September 30, 2021

8,958

8.0

706

(26.9)

739

(27.6)

533

(14.9)

September 30, 2020

8,293

24.0

965

39.5

1,021

42.6

627

15.8

(Note) Comprehensive income: Nine months ended September 30, 2021: ¥ 641 million [0.5%] Nine months ended September 30, 2020: ¥ 638 million [29.9%]

Basic earnings

Diluted earnings

per share

per share

Nine months ended

Yen

Yen

September 30, 2021

100.93

100.29

September 30, 2020

120.30

119.64

(2) Consolidated Financial Position

Total assets

Net assets

Equity ratio

Million yen

Million yen

%

As of September 30, 2021

8,355

2,784

33.1

As of December 31, 2020

8,211

2,544

30.6

(Reference) Equity: As of September 30, 2021: ¥ 2,761 million As of December 31, 2020: ¥ 2,515 million

1

2. Dividends

Annual dividends

1st

2nd

3rd

Year-end

Total

quarter-end

quarter-end

quarter-end

Yen

Yen

Yen

Yen

Yen

Fiscal year ended December 31,

0.00

0.00

0.00

81.00

81.00

2020

Fiscal year ending December 31,

0.00

0.00

0.00

2021

Fiscal year ending December 31,

81.00

81.00

2021 (Forecast)

(Note) Revision to the dividends forecast most recently announced: No

3. Consolidated Financial Results Forecast for the Fiscal Year Ending December 31, 2021 (from January 1, 2021 to December 31, 2021)

(% indicates changes from the previous corresponding period.)

Net sales

Operating profit

Ordinary profit

Profit attributable

Basic earnings

to owners of parent

per share

Million yen

%

Million yen

%

Million yen

%

Million yen

%

Yen

Full year

13,223

20.1

1,114

20.2

1,127

14.6

795

(4.2)

150.65

(Note) Revision to the financial results forecast most recently announced: No

2

* Notes:

  1. Changes in significant subsidiaries during the nine months ended September 30, 2021: No (Changes in specified subsidiaries resulting in changes in scope of consolidation)
    New: None
    Excluded: None
  2. Adoption of special accounting methods in preparation of quarterly consolidated financial statements: No
  3. Changes in accounting policies, changes in accounting estimates and retrospective restatement
    1. Changes in accounting policies due to the revision of accounting standards: No
    2. Changes in accounting policies other than 1) above: No
    3. Changes in accounting estimates: No
    4. Retrospective restatement: No
  4. Total number of issued shares (common shares)
    1. Total number of issued shares at the end of the period (including treasury stock):

September 30, 2021: 5,468,700 shares

December 31, 2020: 5,468,700 shares

  1. Total number of treasury stock at the end of the period: September 30, 2021: 177,288 shares
    December 31, 2020: 191,288 shares
  2. Average number of shares during the period:

Nine months ended September 30, 2021: 5,287,800 shares

Nine months ended September 30, 2020: 5,214,196 shares

  • These quarterly financial results are outside the scope of quarterly review by certified public accountants or audit firms.
  • Explanation of the proper use of financial results forecast and other notes

The statements concerning future performance presented in this document are based on currently available information and certain preconditions which the Company believes to be reasonable at this time and does not constitute a guarantee of the Company to achieve. Actual results may be substantially different from these forecasts presented herein due to various factors.

3

Attachments

  • Original document
  • Permalink

Disclaimer

GMO Pepabo Inc. published this content on 08 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 November 2021 06:37:04 UTC.